Related Experiment Video
Updated: Aug 4, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Resistance against reverse transcriptase inhibitors
1Departments of Medicine, Pathology, and Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555-0835, USA. wobrien@utmb.edu.
Summary
Drug resistance limits antiretroviral therapy effectiveness in human immunodeficiency virus (HIV)-infected patients. New mutation complexes can cause broad cross-resistance, necessitating improved resistance assays for clinical use.
Area of Science:
- Virology
- Immunology
- Pharmacology
Background:
- Antiretroviral therapy (ART) response in HIV-infected patients is often limited by the development of drug resistance.
- HIV's high mutation and replication rates, coupled with selective drug pressure, drive the emergence of resistance.
- Highly Active Antiretroviral Therapy (HAART), using multiple drugs, achieves durable viral suppression but is challenged by resistance.
Purpose of the Study:
- To review the mechanisms of drug resistance in HIV.
- To discuss the impact of combination therapy on viral load reduction.
- To highlight the challenges and future directions for HIV drug resistance assays.
Main Methods:
- Review of existing literature on HIV drug resistance.
- Analysis of the impact of nucleoside reverse transcriptase inhibitors (RTIs) and other ART components.
- Discussion of genotypic and phenotypic resistance assay development.
Main Results:
- Emergence of drug resistance is a primary limitation to effective ART in HIV.
- HAART, particularly with multiple RTIs, leads to significant viral load reduction and suppression.
- Specific amino acid changes confer resistance to RTIs, with new mutation complexes causing broad cross-resistance.
Conclusions:
- Durable viral suppression with ART is achievable but threatened by emerging drug resistance.
- Further development and refinement of genotypic and phenotypic resistance assays are crucial for widespread clinical application.
- Understanding resistance mechanisms is key to optimizing HIV treatment strategies.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:29Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...